Effects of treatment with eluxadoline on abdominal pain in patients with IBS-D: Additional post hoc analyses of Phase 3 trials.
Anthony J LemboPaul S CovingtonLeonard S DoveDavid A AndraePublished in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2020)
Despite small effect sizes, eluxadoline demonstrated consistent and sustained improvement in WAP compared to placebo across a range of prospective and post hoc analyses. Assessing WAP response across a range of measures is important for fully understanding a treatment's efficacy.
Keyphrases